Adherium’s COPD digital intervention study
Adherium’s COPD digital intervention study A new groundbreaking study, the 12-month MAGNIFY trial, reveals that digital medication adherence support can make a real difference for high-risk COPD patients! Here’s what the findings show: – 23% reduction in treatment failure risk – 11% lower exacerbation rates – Significant benefits for patients with FEV1<80%, no previous exacerbations, […]
